265 related articles for article (PubMed ID: 22467867)
1. Physical and functional interaction between ribosomal protein L11 and the tumor suppressor ARF.
Dai MS; Challagundla KB; Sun XX; Palam LR; Zeng SX; Wek RC; Lu H
J Biol Chem; 2012 May; 287(21):17120-17129. PubMed ID: 22467867
[TBL] [Abstract][Full Text] [Related]
2. Perturbation of 60 S ribosomal biogenesis results in ribosomal protein L5- and L11-dependent p53 activation.
Sun XX; Wang YG; Xirodimas DP; Dai MS
J Biol Chem; 2010 Aug; 285(33):25812-21. PubMed ID: 20554519
[TBL] [Abstract][Full Text] [Related]
3. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway.
Zhang Y; Wolf GW; Bhat K; Jin A; Allio T; Burkhart WA; Xiong Y
Mol Cell Biol; 2003 Dec; 23(23):8902-12. PubMed ID: 14612427
[TBL] [Abstract][Full Text] [Related]
4. Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway.
Horn HF; Vousden KH
Oncogene; 2008 Oct; 27(44):5774-84. PubMed ID: 18560357
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the MDM2-p53 pathway by ribosomal protein L11 involves a post-ubiquitination mechanism.
Dai MS; Shi D; Jin Y; Sun XX; Zhang Y; Grossman SR; Lu H
J Biol Chem; 2006 Aug; 281(34):24304-13. PubMed ID: 16803902
[TBL] [Abstract][Full Text] [Related]
6. The in vivo role of the RP-Mdm2-p53 pathway in signaling oncogenic stress induced by pRb inactivation and Ras overexpression.
Pan W; Issaq S; Zhang Y
PLoS One; 2011; 6(6):e21625. PubMed ID: 21747916
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.
Lindström MS; Jin A; Deisenroth C; White Wolf G; Zhang Y
Mol Cell Biol; 2007 Feb; 27(3):1056-68. PubMed ID: 17116689
[TBL] [Abstract][Full Text] [Related]
8. Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress.
Bursać S; Brdovčak MC; Pfannkuchen M; Orsolić I; Golomb L; Zhu Y; Katz C; Daftuar L; Grabušić K; Vukelić I; Filić V; Oren M; Prives C; Volarevic S
Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20467-72. PubMed ID: 23169665
[TBL] [Abstract][Full Text] [Related]
9. Depletion of ribosomal protein L37 occurs in response to DNA damage and activates p53 through the L11/MDM2 pathway.
Llanos S; Serrano M
Cell Cycle; 2010 Oct; 9(19):4005-12. PubMed ID: 20935493
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5.
Dai MS; Lu H
J Biol Chem; 2004 Oct; 279(43):44475-82. PubMed ID: 15308643
[TBL] [Abstract][Full Text] [Related]
11. Ribosomal stress induces L11- and p53-dependent apoptosis in mouse pluripotent stem cells.
Morgado-Palacin L; Llanos S; Serrano M
Cell Cycle; 2012 Feb; 11(3):503-10. PubMed ID: 22262176
[TBL] [Abstract][Full Text] [Related]
12. GRWD1 negatively regulates p53 via the RPL11-MDM2 pathway and promotes tumorigenesis.
Kayama K; Watanabe S; Takafuji T; Tsuji T; Hironaka K; Matsumoto M; Nakayama KI; Enari M; Kohno T; Shiraishi K; Kiyono T; Yoshida K; Sugimoto N; Fujita M
EMBO Rep; 2017 Jan; 18(1):123-137. PubMed ID: 27856536
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
Meng X; Carlson NR; Dong J; Zhang Y
Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025
[TBL] [Abstract][Full Text] [Related]
14. Recruitment of RPL11 at promoter sites of p53-regulated genes upon nucleolar stress through NEDD8 and in an Mdm2-dependent manner.
Mahata B; Sundqvist A; Xirodimas DP
Oncogene; 2012 Jun; 31(25):3060-71. PubMed ID: 22081073
[TBL] [Abstract][Full Text] [Related]
15. Ribosomal proteins L11 and L5 activate TAp73 by overcoming MDM2 inhibition.
Zhou X; Hao Q; Zhang Q; Liao JM; Ke JW; Liao P; Cao B; Lu H
Cell Death Differ; 2015 May; 22(5):755-66. PubMed ID: 25301064
[TBL] [Abstract][Full Text] [Related]
16. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.
Stott FJ; Bates S; James MC; McConnell BB; Starborg M; Brookes S; Palmero I; Ryan K; Hara E; Vousden KH; Peters G
EMBO J; 1998 Sep; 17(17):5001-14. PubMed ID: 9724636
[TBL] [Abstract][Full Text] [Related]
17. Regulation of HDM2 activity by the ribosomal protein L11.
Lohrum MA; Ludwig RL; Kubbutat MH; Hanlon M; Vousden KH
Cancer Cell; 2003 Jun; 3(6):577-87. PubMed ID: 12842086
[TBL] [Abstract][Full Text] [Related]
18. An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction.
Macias E; Jin A; Deisenroth C; Bhat K; Mao H; Lindström MS; Zhang Y
Cancer Cell; 2010 Sep; 18(3):231-43. PubMed ID: 20832751
[TBL] [Abstract][Full Text] [Related]
19. Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress.
Zhou X; Hao Q; Liao J; Zhang Q; Lu H
Oncogene; 2013 Jan; 32(3):388-96. PubMed ID: 22391559
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2.
Dai MS; Sun XX; Lu H
Mol Cell Biol; 2008 Jul; 28(13):4365-76. PubMed ID: 18426907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
